Cyclamic Acid

Cyclamic Acid

SCHEMBL414415

O=S(=O)([O-])NC1CCCCC1.O=S(=O)([O-])NC1CCCCC1.[Ni+2]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.91
CA7 P43166 3/20 0.91
CA14 Q9ULX7 3/20 0.91
CA9 Q16790 1/20 0.91
CA1 P00915 2/20 0.61
CA2 P00918 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 1/20 0.50
RECQL P46063 1/20 0.50
ALDH1A1 P00352 6/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclamic Acid SCHEMBL28963281 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL692781 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL4592737 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL9591547 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL2188654 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL1457947 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL1532404 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL10856451 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL66221 0.95 CA12 (1.00) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL28154733 0.95 CA12 (1.00) CA12CA7CA14CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3202124-A None JP disclosed
EP-2598864-B1 ELECTRODE, ANALYTE SENSOR AND METHOD FOR PREPARING AN ELECTRODE PARKER HANNIFIN CORP (US) 2024-06-12 EP disclosed
EP-3877370-B1 CYCLAM DERIVATIVES IMMOBILISED ON A SOLID SUPPORT AND USES THEREOF FOR CATALYSIS AND/OR FOR THE DETECTION OF IONS UNIV BRETAGNE OCCIDENTALE (FR) 2023-08-02 EP disclosed
EP-3985383-A1 ANALYTE SENSOR Parker Hannifin Corp. (US) 2022-04-20 EP disclosed
EP-3877370-A1 CYCLAM DERIVATIVES IMMOBILISED ON A SOLID SUPPORT AND USES THEREOF FOR CATALYSIS AND/OR FOR THE DETECTION OF IONS Université de Bretagne Occidentale (FR) 2021-09-15 EP disclosed
US-10324060-B2 Analyte sensor PARKER-HANNIFIN CORPORATION (US) 2019-06-18 US disclosed
EP-3486645-A2 ANALYTE SENSOR Parker-Hannificn Corporation (US) 2019-05-22 EP disclosed
EP-2411793-B1 pH METER DEVICE PARKER HANNIFIN CORP (US) 2019-05-08 EP disclosed
US-10261043-B2 Analyte sensor PARKER-HANNIFIN CORPORATION (US) 2019-04-16 US disclosed
EP-2807477-B1 ANALYTE SENSOR PARKER HANNIFIN CORP (US) 2019-01-02 EP disclosed
US-5382332-A Aqueous solution, nickel tetraazatetradecane catalyst NISSAN MOTOR CO., LTD. (JP) 1995-01-17 US disclosed
EP-0342110-B1 Macrocylic amine complexes for ligand extraction and generation AQUANAUTICS CORP (US) 1994-08-17 EP disclosed
US-5284563-A Electrode catalyst for electrolytic reduction of carbon dioxide gas NISSAN MOTOR CO., LTD. (JP) 1994-02-08 US disclosed
US-5284563-A Electrode catalyst for electrolytic reduction of carbon dioxide gas NISSAN MOTOR CO., LTD. (JP) 1994-02-08 US disclosed
JP-H03202124-A TREATMENT OF GAS CONTAINING NITROGEN OXIDE MATSUSHITA ELECTRIC IND CO LTD 1991-09-03 JP disclosed
US-4952289-A REVERSIBLY-BINDING, ELECTROCHEMICALLY-ACTIVE TRANSITION METAL COMPLEXES; DEOXYGENATION; WASTES; EXHAUXT GASES AQUANAUTICS CORPORATION (US) 1990-08-28 US disclosed
EP-0342110-A1 Macrocylic amine complexes for ligand extraction and generation AQUANAUTICS CORPORATION (a Delaware corporation) (US) 1989-11-15 EP disclosed
EP-0283751-A2 Polyalkylamine complexes for ligand extraction and generation AQUANAUTICS CORPORATION (a Californian corporation) (US) 1988-09-28 EP disclosed
WO-1988006641-A1 POLYALKYLAMINE COMPLEXES FOR LIGAND EXTRACTION AND GENERATION AQUANAUTICS CORPORATION (US) 1988-09-07 WO disclosed
US-4668349-A Acid promoted electrocatalytic reduction of carbon dioxide by square planar transition metal complexes THE STANDARD OIL COMPANY (US) 1987-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10261043-B2 Analyte sensor HAO2, PRDX1, MPO CA12 33/4885CA7 132/4885CA14 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.